| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| AR protein | 3 | 0 | 0 | 3 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
| estrogen nuclear receptor alpha | 3 | 0 | 0 | 3 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| IDH1 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 2 | 2 | 5 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Glutamate receptor 2 | 3 | 0 | 0 | 3 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 2 | 3 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 2 | 4 |
| Adenosine receptor A2b | 0 | 0 | 1 | 2 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 2 | 5 |
| Adenosine receptor A2a | 0 | 1 | 2 | 3 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GLS protein | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 3 | 0 | 4 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain B, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain B, Transthyretin | 0 | 0 | 1 | 1 |
| Luciferase | 1 | 0 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 2 | 0 | 0 | 2 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| TDP1 protein | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
| Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
| progesterone receptor | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
| retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
| peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| geminin | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
| G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Triosephosphate isomerase | 0 | 1 | 0 | 1 |
| Interferon beta | 3 | 0 | 0 | 3 |
| Glucocorticoid receptor | 1 | 2 | 2 | 8 |
| Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 0 | 1 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Androgen receptor | 1 | 2 | 1 | 5 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 1 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 1 | 0 | 2 |
| Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 1 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 1 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 1 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 1 | 0 | 2 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Cyclin homolog | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 1 | 1 | 0 | 2 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 1 | 1 | 0 | 2 |
| Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Estrogen receptor | 1 | 2 | 1 | 4 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 2 | 1 | 5 |
| Tegument protein VP16 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 3 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 1 | 2 | 1 | 5 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Progesterone receptor | 0 | 0 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 1 | 2 | 1 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Sulfate anion transporter 1 | 0 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |